For 40 years, Daffodil Day (@CancerCouncilOz) has been a powerful reminder of how far cancer research has come. At IR Department, we are privileged to be supporting companies dedicated to developing treatments for cancers of many kinds. More here: https://t.co/YKg6NeKOVw
The 20th annual edition of Bioshares has officially begun in Queenstown, NZ with two full days packed with presentations, meetings and opportunities to hear from some of the companies at the cutting edge of biotech innovation. #ASXbiotech
Final call for investors 📣
Join Neurizon Therapeutics $NUZ for a special briefing on 29 July, 5–7pm in Melbourne CBD.
Updates: HEALEY #ALS Platform Trial, manufacturing milestones & NUZ-001.
RSVP: [email protected]
https://t.co/gxje1AKCPH
Final call for investors 📣
Join Neurizon Therapeutics $NUZ for a special briefing on 29 July, 5–7pm in Melbourne CBD.
Updates: HEALEY #ALS Platform Trial, manufacturing milestones & NUZ-001.
RSVP: [email protected]
https://t.co/gxje1AKCPH
Great to see @StockheadAU's writeup from Scott Power, Senior Healthcare Analyst at @MorgansAU on the 5 innovative #ASX companies that will be showcased at HealthInvest on Wed, 3 June 2026. ($DMX, $RAC, $SOM $BIO, $MX1). Registration link in the comments. https://t.co/HfhUDthjbF
At the @ImpactInvestAus Summit Asia Pacific, Jane Lowe led an insightful panel with Christian Toouli (FivepHusion), Kerri Lee Sinclair (AusBiotech) & Justin Coombs (AusHealth) on unlocking capital to accelerate life-saving tech. 📸 Photos below:
#ImpactInvesting#Biotech
Next week in Sydney, Jane Lowe leads a panel on Lifesaving: Impact Investing in Biotech Companies at the Impact Investment Summit.
Joined by:
• Christian Toouli
• Justin Coombs
• Kerri Lee Sinclair
🔗 https://t.co/EDwkGjQUnS
Thanks for having us @EYnews and BioNSW @PharmaDispatch at this morning’s breakfast briefing - it was insightful to hear different perspectives on what goes into the valuation of biotech and healthcare organisations at every stage of a company life cycle. #biotechinvesting
Today is Intl Day of Women & Girls in Science, highlighting gender equality's role in scientific progress 👩🔬
We’re proud to have a team which benefits from strong female representation at multiple levels, working to support clients advancing healthcare
🔗https://t.co/1bylAz6st6
IR Department was proud to support #AusBiotechInvest 2025 as Communications Partner last week. 23 innovative biotechs pitched to global investors and partners. Thanks @AusBiotech. Learn more: https://t.co/wG42EH1RrY
#Biotech#LifeSciences#Investors
On 24 September, #HealthInvest Sydney brought together Australia's brightest in life #sciences & #investment. Our new blog post recaps the insightful evening, a breakdown of key market themes from @morgansAU and link to the full media coverage.
🔗https://t.co/3r1TLvPzfL
#HealthInvest is back! Hear from 5 innovative ASX-listed companies shaping the future of healthcare, presenting with @morgansAU@ir_department & @StockheadAU.
Register free: https://t.co/giJUGtxqk0
🌱 The IR Department team had the pleasure of attending the 19th Bioshares Biotech Summit in Hobart last week.
It was fantastic to come together with the industry. The energy, passion, and hard work on display were all inspiring.
Looking forward to Queenstown in 2026!
📍Live from Hobart!
Team IR Department is at the 19th #Bioshares Biotech Summit (7–8 Aug) in Hobart, joining top biotech & life sciences innovators to share insights & make connections
35 ASX-listed companies. 2 days of presentations & conversations. Let’s connect if you’re here!